DRW Securities LLC Invests $503,000 in HCA Healthcare, Inc. (NYSE:HCA)

DRW Securities LLC bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 1,573 shares of the company’s stock, valued at approximately $503,000.

A number of other institutional investors also recently modified their holdings of HCA. MFA Wealth Advisors LLC bought a new position in HCA Healthcare in the 2nd quarter worth about $27,000. Unique Wealth Strategies LLC purchased a new position in HCA Healthcare during the second quarter valued at approximately $28,000. Bangor Savings Bank lifted its stake in HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 45 shares in the last quarter. GPS Wealth Strategies Group LLC increased its holdings in shares of HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares during the period. Finally, LifeSteps Financial Inc. bought a new stake in HCA Healthcare during the first quarter valued at $33,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $405.71 on Tuesday. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $409.42. The company has a market cap of $106.26 billion, a price-to-earnings ratio of 20.22, a price-to-earnings-growth ratio of 1.46 and a beta of 1.67. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The company has a 50-day moving average price of $372.34 and a 200-day moving average price of $341.21.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.97 by $0.53. The firm had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business’s revenue was up 10.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $4.29 earnings per share. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be issued a $0.66 dividend. The ex-dividend date is Monday, September 16th. This represents a $2.64 annualized dividend and a yield of 0.65%. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

Wall Street Analyst Weigh In

HCA has been the subject of a number of research analyst reports. Truist Financial lifted their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. Morgan Stanley started coverage on shares of HCA Healthcare in a report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target on the stock. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Oppenheimer lifted their price target on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Finally, Wells Fargo & Company raised their price objective on HCA Healthcare from $315.00 to $365.00 and gave the company an “equal weight” rating in a report on Tuesday, July 30th. Five investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $359.89.

Insiders Place Their Bets

In related news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the sale, the senior vice president now owns 40,449 shares in the company, valued at approximately $14,569,729.80. The disclosure for this sale can be found here. In the last quarter, insiders have sold 17,202 shares of company stock worth $6,407,273. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.